Evidence map›Paper›PMID 32483195›Full record

ArticleNature communications2020

Integrating whole-genome sequencing within the National Antimicrobial Resistance Surveillance Program in the Philippines.

Silvia Argimón, Melissa A L Masim, June M Gayeta, Marietta L Lagrada, Polle K V Macaranas, Victoria Cohen, Marilyn T Limas, Holly O Espiritu, Janziel C Palarca, Jeremiah Chilam and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Emerging carbapenem-resistantMicrobiology spectrum · 2025
    Article
  20. Advancements in AI-driven drug sensitivity testing research.Frontiers in cellular and infection microbiology · 2025
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Silvia ArgimónCentre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-2884-3857
Melissa A L MasimAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.ORCID http://orcid.org/0000-0001-8922-7284
June M GayetaAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Marietta L LagradaAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Polle K V MacaranasAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Victoria CohenCentre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, UK.
Marilyn T LimasAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Holly O EspirituAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Janziel C PalarcaAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Jeremiah ChilamAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Manuel C JamoralinAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Alfred S VillaminAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Janice B BorlasaAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Agnettah M OlorosaAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Lara F T HernandezAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Karis D BoehmeAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Benjamin JeffreyCentre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, UK.
Khalil AbudahabCentre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, UK.
Charmian M HufanoAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
Sonia B SiaAntimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines.
John StellingBrigham and Women's Hospital, Boston, MA, USA.
Matthew T G HoldenUniversity of St Andrews School of Medicine, St Andrews, Scotland, UK.ORCID http://orcid.org/0000-0002-4958-2166
David M Aanensen *Centre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Hinxton, UK. david.aanensen@bdi.ox.ac.uk.
Celia C Carlos *Antimicrobial Resistance Surveillance Reference Laboratory, Research Institute for Tropical Medicine, Muntinlupa, The Philippines. ccarlosphl@yahoo.com.

Funding

WHONET for automated real-time multilevel global microbial surveillanceR01RR025040 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI STELLING, JOHN · 2008 to 2011
$1.4M
Integrating the world's microbiology laboratories into a global microbial surveillance systemU01CA207167 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI STELLING, JOHN · 2016 to 2018
$1.3M
Department of Health 16_136_111Medical Research Council MR/N019296/1NCI NIH HHS U01 CA207167NCRR NIH HHS R01 RR025040
6 · The paper itself

Abstract

National networks of laboratory-based surveillance of antimicrobial resistance (AMR) monitor resistance trends and disseminate these data to AMR stakeholders. Whole-genome sequencing (WGS) can support surveillance by pinpointing resistance mechanisms and uncovering transmission patterns. However, genomic surveillance is rare in low- and middle-income countries. Here, we implement WGS within the established Antimicrobial Resistance Surveillance Program of the Philippines via a binational collaboration. In parallel, we characterize bacterial populations of key bug-drug combinations via a retrospective sequencing survey. By linking the resistance phenotypes to genomic data, we reveal the interplay of genetic lineages (strains), AMR mechanisms, and AMR vehicles underlying the expansion of specific resistance phenotypes that coincide with the growing carbapenem resistance rates observed since 2010. Our results enhance our understanding of the drivers of carbapenem resistance in the Philippines, while also serving as the genetic background to contextualize ongoing local prospective surveillance.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, BacterialGenome, BacterialGenomicsHumansMicrobial Sensitivity TestsPhilippinesSurveys and QuestionnairesWhole Genome SequencingAnti-Bacterial Agents

Identifiers

PMID32483195
PMCPMC7264328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.